Medtronic (NYSE: MDT) is scheduled to report its fiscal 2023 fourth-quarter results on Thursday, May 25. We expect Medtronic
MDT
stock to trade sideways post-Q4 results announcement, with its revenues and earnings expected to align with the street estimates. The company should continue to benefit from its new products and a better pricing environment. Although we expect Medtronic to report in-line results, we believe its stock has little room for growth, as discussed below. Our interactive dashboard analysis of Medtronic’s Earnings Preview has additional details.
(1) Better Pricing To Aid Sales
Subscribe
Gain access to all our Premium contents.
More than 100+ articles.
Buy Article
Unlock this article and gain permanent access to read it.